6 insiders reported 7 Form 4 transactions for Pasithea Therapeutics Corp. (KTTA) over the past 18 months (most recent 2026-06-22). Recent activity: Coastlands Capital LP (Insider) Buy 100,000 shares, STEINMAN LAWRENCE (Director) Buy 133,333 shares, Schneiderman Daniel H (Chief Financial Officer) Buy 26,667 shares, Dumesnil Simon (Director) Buy 33,333 shares, Leahy Emer (Director) Buy 33,333 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-22 | Coastlands Capital LP | Insider | Buy | 100,000 | $53,000 |
| 2025-12-01 | STEINMAN LAWRENCE | Director | Buy | 133,333 | $100,000 |
| 2025-12-01 | Schneiderman Daniel H | Chief Financial Officer | Buy | 26,667 | $20,000 |
| 2025-12-01 | Dumesnil Simon | Director | Buy | 33,333 | $25,000 |
| 2025-12-01 | Leahy Emer | Director | Buy | 33,333 | $25,000 |
| 2025-12-01 | Marques Tiago | Chief Executive Officer | Buy | 33,333 | $25,000 |
| 2025-05-14 | Marques Tiago | Chief Executive Officer | Sell | 960 | $797 |
Source: SEC Form 4 filings · as of 2026-06-22